Ani Pharmaceuticals (ANIP) Prepaid Assets (2010 - 2026)
Ani Pharmaceuticals (ANIP) reported Prepaid Assets of $22.1 million for Q1 2026, down 5.31% on a YoY basis from $23.3 million in Q1 2025, and down 35.45% sequentially from $34.2 million in Q4 2025.
Ani Pharmaceuticals (ANIP) Prepaid Assets (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals (ANIP) has 17 years of Prepaid Assets data on file, last reported at $22.1 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 5.31% year-over-year to $22.1 million; the trailing twelve-month figure through Mar 2026 stood at $22.1 million (down 5.31% YoY), and the FY2025 full-year result was $34.2 million, up 90.35% from the prior year.
- Prepaid Assets retreated to $22.1 million in Q1 2026, from $34.2 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $34.2 million in Q4 2025 to a low of $5.0 million in Q3 2022.
- A 5-year average of $14.7 million and a median of $15.1 million in 2025 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets fell 11.03% in 2023 and surged 133.49% in 2024, its largest moves.
- Tracing ANIP's Prepaid Assets over 5 years: stood at $8.4 million in 2022, then soared by 107.46% to $17.4 million in 2023, then rose by 3.3% to $18.0 million in 2024, then surged by 90.35% to $34.2 million in 2025, then tumbled by 35.45% to $22.1 million in 2026.
- Business Quant data shows ANIP's Prepaid Assets at $22.1 million in Q1 2026, $34.2 million in Q4 2025, and $18.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.09 Mn |
| Dec 31, 2025 | 34.22 Mn |
| Sep 30, 2025 | 18.55 Mn |
| Jun 30, 2025 | 15.11 Mn |
| Mar 31, 2025 | 23.33 Mn |
| Dec 31, 2024 | 17.98 Mn |
| Sep 30, 2024 | 17.48 Mn |
| Jun 30, 2024 | 14.00 Mn |
| Mar 31, 2024 | 16.05 Mn |
| Dec 31, 2023 | 17.40 Mn |
| Sep 30, 2023 | 10.69 Mn |
| Jun 30, 2023 | 8.25 Mn |
| Mar 31, 2023 | 6.87 Mn |
| Dec 31, 2022 | 8.39 Mn |
| Sep 30, 2022 | 4.97 Mn |
| Jun 30, 2022 | 6.03 Mn |
| Mar 31, 2022 | 7.73 Mn |
| Dec 31, 2021 | 7.59 Mn |
| Sep 30, 2021 | 4.70 Mn |
| Jun 30, 2021 | 4.88 Mn |